Skip to main content
. 2009 May 1;6:46. doi: 10.1186/1743-422X-6-46

Table 2.

HLA-class I allele frequencies of HCV infected subjects

Allele Chronic(%) 2n = 112 Clearance (%) 2n = 98 Odds Ratio 95% CI p-value
A*01 15.2 9.18 2.05 0.79–5.32 0.14
A*02 26.8 26.0 1.04 0.48–2.24 0.92
Caucasian 30.3 17.4 2.07 0.82–5.21 0.12
non-Cauc 21.7 32.7 0.57 0.23–1.42 0.23
A*03* 9.82 16.7 0.54 0.24–1.20 0.14
A*11 3.57 6.25 0.55 0.15–2.08 0.38
A*23 1.79 4.17 0.42 0.07–2.38 0.33
A*24 10.7 15.0 0.94 0.37–2.38 0.90
A*25 1.79 1.25 1.78 0.16–20.2 0.64
A*29 5.34 1.25 0.18 0.02–1.50 0.12
A*30 7.14 3.12 2.56 0.64–10.2 0.19
A*31 3.57 5.21 0.68 0.17–2.68 0.58
A*32 1.79 4.17 0.42 0.07–2.38 0.33
A*33 2.68 1.04 2.71 0.27–27.0 0.39
A*68 2.68 4.17 0.64 0.14–2.08 2.99
A*74 2.68 1.04 0.37 0.04–3.66 0.62
Cw*01 1.79 4.08 0.57 0.09–3.55 0.55
Cw*02 9.84 7.16 1.47 0.52–4.13 0.47
Cw*03 10.7 9.18 1.21 0.46–3.18 0.70
Cw*04 16.9 13.2 1.31 0.56–3.06 0.53
Cw*05 0.89 7.16 0.12 0.01–0.97 0.03
Cw*06 8.94 9.18 1.11 0.40–3.09 0.84
Cw*07 28.6 28.6 0.88 0.41–1.91 0.75
Cw*08 4.46 3.06 1.18 0.25–5.55 0.84
Cw*12 3.58 6.12 0.55 0.15–2.08 0.38
Cw*15 3.58 2.05 1.81 0.32–10.3 0.51
Cw*16 7.15 8.16 0.85 0.29–2.48 0.77

*: A*03 is protective for non-Caucasians, OR = 0.20, 95% CI = 0.04–1.01, P = 0.04

Note: Only those alleles except Cw*05 with more than 1.0% frequency in both comparison groups are shown.

Non-Cauc: non-Caucasians.